Acetyl-L-carnitine — usually shortened to ALCAR — is a brain supplement built around energy. It’s the acetylated form of carnitine, the molecule your cells use to shuttle fatty acids into the mitochondria where they get burned for fuel. The brain is an energy-hungry organ, so the pitch is that ALCAR supports mitochondrial function, and from there, cognition and mood. The evidence is genuinely interesting in older adults and in people with depression, and more uncertain in healthy young people.

This guide covers what acetyl-L-carnitine does, where the research holds up, how it differs from the choline-based brain supplements, and how to dose it.
Quick answer
- What it is: the acetyl ester of L-carnitine, involved in mitochondrial fatty-acid transport
- Mechanism: supports mitochondrial energy production; also a source of acetyl groups for acetylcholine and crosses into the brain
- Typical dose: 1,000–2,000 mg/day, usually split into two doses
- Best evidence for: cognition in older adults with mild impairment; depressive symptoms
- Weaker evidence for: cognitive boosts in healthy young people
- Timeline: mood and cognitive effects build over weeks
- Safety: generally well tolerated; mild GI effects and occasional restlessness
How acetyl-L-carnitine works
Carnitine’s day job is transport. It carries long-chain fatty acids across the inner mitochondrial membrane so they can be broken down for energy. Without enough carnitine, that fuel pipeline slows down. Acetyl-L-carnitine is a form that crosses the blood-brain barrier more readily than plain carnitine, which is why it’s the version used in brain research.
According to PubMed, a foundational review describes how feeding acetyl-L-carnitine (alongside lipoic acid) helped restore mitochondrial function and improved cognition and activity in aged animals, framing mitochondrial decay as a driver of aging and ALCAR as a way to push back on it.1 On top of the energy angle, the acetyl group it carries can contribute to acetylcholine synthesis — so there’s a cholinergic side effect to its main mitochondrial role.
The brain runs on enormous amounts of energy — roughly a fifth of your body’s total despite being a small fraction of its weight — which is why mitochondrial support is a recurring theme in cognitive research. When mitochondria run less efficiently with age, neurons have less energy to work with, and that shortfall is one proposed contributor to age-related cognitive slowing. Creatine targets the same broad problem from a different angle (the phosphocreatine energy buffer), which is why the two often come up together in discussions of brain energy.

Acetyl-L-carnitine and cognition
This is where ALCAR has its longer track record. A Cochrane systematic review of acetyl-L-carnitine for dementia found evidence of benefit on some clinical and cognitive measures, while noting that the overall quality and consistency of trials limited firm conclusions.2 Broader reviews have pointed to meta-analytic evidence that ALCAR significantly outperformed placebo for mild cognitive impairment and mild Alzheimer’s disease.1
As with most brain supplements, the cleanest benefits cluster in older adults and people with some baseline impairment. For healthy young people hoping for a study edge, the cognition evidence is thin — treat any benefit as plausible but unproven. It’s also worth noting that several of the older positive trials were short and modest in size, so the effect, where it exists, is best described as gentle support rather than a sharp boost.
If your focus problems feel more like fatigue and fog than true decline, see what is brain fog, and our ways to improve memory guide covers habits that complement any supplement.
Acetyl-L-carnitine and mood
The mood evidence is arguably ALCAR’s most compelling story. According to PubMed, a 2018 systematic review and meta-analysis found that acetyl-L-carnitine supplementation significantly reduced depressive symptoms compared with placebo, with an effect comparable to standard antidepressants in some comparisons and notably better tolerability.3 A multicenter randomized trial in elderly patients with dysthymic disorder found L-acetylcarnitine comparable to fluoxetine, with a faster onset and fewer side effects.4
That’s a stronger and more consistent body of evidence than most supplements can claim for mood. The honest framing: it’s promising, particularly in older adults, but it isn’t a replacement for proper treatment. If you’re dealing with depression, work with a clinician — ALCAR might be a reasonable adjunct, not a substitute for care.
Suggested read: Creatine for Women: Benefits, Dose, and Lifespan Effects
How to dose acetyl-L-carnitine
| Goal | Dose | Timing | Notes |
|---|---|---|---|
| Cognition (older adults) | 1,500–2,000 mg/day | Split, with or without food | Range used in cognitive trials |
| Mood support | 1,000–3,000 mg/day | Split through the day | Range across depression studies |
| General use | 500–1,000 mg/day | Once or twice daily | Conservative starting point |
Practical points:
- Split the dose. Two servings (morning and early afternoon) are gentler on the stomach than one large one.
- Avoid late doses. Some people find ALCAR mildly stimulating, so an evening dose can disrupt sleep.
- Give it weeks. The mood and cognitive effects in the trials built over time, not overnight.
How it compares to other brain supplements
Acetyl-L-carnitine sits in a different lane from the choline-based options:
- Citicoline and alpha-GPC are choline sources feeding acetylcholine — a neurotransmitter mechanism
- Phosphatidylserine works on cell-membrane structure
- Acetyl-L-carnitine is primarily a mitochondrial-energy play, with mood evidence as its strongest suit
Because it overlaps least with the cholinergic supplements, some people pair ALCAR with one of them. For the wider picture, see our nootropics overview and the nootropic brain supplements guide.
What to expect, realistically
ALCAR is a gradual supplement, not a same-day booster. Honest expectations:
- You won’t feel a dramatic acute effect, though some notice mild alertness
- If you’re an older adult with mild cognitive impairment, the evidence is on your side
- If you’re dealing with low mood, the antidepressant data are encouraging — but loop in a clinician
- If you’re young and healthy, the cognitive benefit is uncertain
And no supplement replaces the basics. A brain-supporting diet does more long-term than ALCAR — our brain foods guide covers the eating pattern that carries the most weight.
Suggested read: Creatine for Older Adults: Muscle, Bone, and Safe Use
Safety and side effects
Acetyl-L-carnitine is generally well tolerated. Common, mild side effects include:
- GI upset, nausea, or stomach cramps
- Restlessness or trouble sleeping if taken late
- A fishy body odor at higher doses (a known carnitine quirk)
Cautions:
- Thyroid conditions. Carnitine may interfere with thyroid hormone action — check with your doctor if you have a thyroid disorder.
- Seizure history. Some reports link carnitine supplementation to increased seizure frequency in susceptible people.
- Blood thinners. ALCAR may interact with anticoagulants like warfarin; discuss with your prescriber.
- Pregnancy and breastfeeding. Not well studied — best avoided unless your provider advises it.
Bottom line
Acetyl-L-carnitine (ALCAR) is an energy-focused brain supplement that supports mitochondrial fatty-acid transport and crosses into the brain, with a side contribution to acetylcholine. Its cognition evidence is real but modest, clustered in older adults with mild impairment, and its mood evidence is arguably its strongest suit — a meta-analysis found it reduced depressive symptoms with good tolerability. Dose 1,000–2,000 mg/day split into two servings, avoid late doses, and give it weeks. It’s not a substitute for treating depression or for the fundamentals of sleep, exercise, and diet. For a different mechanism, the choline-based citicoline and alpha-GPC, or the membrane-based phosphatidylserine, are worth comparing.
Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Annals of the New York Academy of Sciences. 2004;1033:108-16. PubMed | DOI ↩︎ ↩︎
Hudson S, Tabet N. Acetyl-L-carnitine for dementia. Cochrane Database of Systematic Reviews. 2003;(2):CD003158. PubMed | DOI ↩︎
Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosomatic Medicine. 2018;80(2):154-159. PubMed | DOI ↩︎
Bersani G, Meco G, Denaro A, Liberati D, Colletti C, Nicolai R, et al. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. European Neuropsychopharmacology. 2013;23(10):1219-25. PubMed | DOI ↩︎





